DSIP stands for delta sleep-inducing peptide and has been investigated in sleep research. Its name does not prove deep-sleep or insomnia-treatment benefits; human findings need to be distinguished from animal experiments.
What the research shows
A 1992 double-blind study in 16 people with chronic insomnia found weak changes in some sleep measures without a clear subjective-quality improvement. A 2024 mouse study used the DSIP-CBBBP fusion construct, not standalone DSIP in people. [1] [2] [3]
Related substances appeared on the FDA’s 2026 compounding agenda; this is not product approval. [3]
Distinguishing substances and products
Standalone DSIP and DSIP-CBBBP are distinct research materials. A graph for one should not be used to validate the other or an unidentified commercial vial.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Does the DSIP name prove deeper sleep?
No. A substance name is not a clinical outcome.
Does DSIP-CBBBP evidence validate standalone DSIP?
Not automatically. It is a fusion construct, and the cited study used mice.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.